Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surgery and HIPEC for Adrenocortical Carcinoma
NCT03127774Phase 2Active, not recruiting
- Sponsor
- Columbia University
- Start
- Sep 2017
- Primary completion
- Dec 2026
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Cisplatin micelle injection (HA132) in adrenocortical carcinoma (ACC), sponsored by Columbia University. Started Sep 2017; status: active, not recruiting.
02
Drugs
Cisplatin micelle injection (HA132)
03
Conditions
adrenocortical carcinoma (ACC)
Beyond the preview
Go deeper on NCT03127774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03127774.